The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Shane Darke

National Drug and Alcohol Research Centre

University of New South Wales

Sydney

NSW, 2052, Australia. Electronic address:

[email]@unsw.edu.au

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, 2052, Australia. Electronic address:. 2002 - 2012

References

  1. Comparative patterns of cognitive performance amongst opioid maintenance patients, abstinent opioid users and non-opioid users. Darke, S., McDonald, S., Kaye, S., Torok, M. Drug. Alcohol. Depend (2012) [Pubmed]
  2. Retention, early dropout and treatment completion among therapeutic community admissions. Darke, S., Campbell, G., Popple, G. Drug. Alcohol. Rev (2012) [Pubmed]
  3. Oxycodone poisoning: not just the 'usual suspects'. Darke, S. Addiction (2011) [Pubmed]
  4. Benzodiazepine use among heroin users: baseline use, current use and clinical outcome. Darke, S., Ross, J., Mills, K., Teesson, M., Williamson, A., Havard, A. Drug. Alcohol. Rev (2010) [Pubmed]
  5. Comparative toxicology of intentional and accidental heroin overdose. Darke, S., Duflou, J., Torok, M. J. Forensic Sci. (2010) [Pubmed]
  6. A reduction in blood morphine concentrations amongst heroin overdose fatalities associated with a sustained reduction in street heroin purity. Darke, S., Duflou, J., Torok, M. Forensic Sci. Int. (2010) [Pubmed]
  7. The comparative toxicology and major organ pathology of fatal methadone and heroin toxicity cases. Darke, S., Duflou, J., Torok, M. Drug. Alcohol. Depend (2010) [Pubmed]
  8. Cardiovascular disease risk factors and symptoms among regular psychostimulant users. Darke, S., Torok, M., Kaye, S., Duflou, J. Drug. Alcohol. Rev (2010) [Pubmed]
  9. Comparative rates of violent crime among regular methamphetamine and opioid users: offending and victimization. Darke, S., Torok, M., Kaye, S., Ross, J., McKetin, R. Addiction (2010) [Pubmed]
  10. The ageing heroin user: career length, clinical profile and outcomes across 36 months. Darke, S., Mills, K.L., Ross, J., Williamson, A., Havard, A., Teesson, M. Drug. Alcohol. Rev (2009) [Pubmed]
  11. Drugs and violent death: comparative toxicology of homicide and non-substance toxicity suicide victims. Darke, S., Duflou, J., Torok, M. Addiction (2009) [Pubmed]
  12. Patterns of major depression and drug-related problems amongst heroin users across 36 months. Darke, S., Mills, K., Teesson, M., Ross, J., Williamson, A., Havard, A. Psychiatry. Res (2009) [Pubmed]
  13. Toxicology and circumstances of completed suicide by means other than overdose. Darke, S., Duflou, J., Torok, M. J. Forensic Sci. (2009) [Pubmed]
  14. From the can to the coffin: deaths among recently released prisoners. Darke, S. Addiction (2008) [Pubmed]
  15. Toxicology and circumstances of death of homicide victims in New South Wales, Australia 1996-2005. Darke, S., Duflou, J. J. Forensic Sci. (2008) [Pubmed]
  16. Truth is not always found in the laboratory. Darke, S. Addiction (2008) [Pubmed]
  17. Comparative toxicology of fatal heroin overdose cases and morphine positive homicide victims. Darke, S., Duflou, J., Kaye, S. Addiction (2007) [Pubmed]
  18. Patterns of nonfatal heroin overdose over a 3-year period: findings from the Australian treatment outcome study. Darke, S., Williamson, A., Ross, J., Mills, K.L., Havard, A., Teesson, M. J. Urban. Health (2007) [Pubmed]
  19. Borderline personality disorder and persistently elevated levels of risk in 36-month outcomes for the treatment of heroin dependence. Darke, S., Ross, J., Williamson, A., Mills, K.L., Havard, A., Teesson, M. Addiction (2007) [Pubmed]
  20. Patterns of sustained heroin abstinence amongst long-term, dependent heroin users: 36 months findings from the Australian Treatment Outcome Study (ATOS). Darke, S., Ross, J., Mills, K.L., Williamson, A., Havard, A., Teesson, M. Addict. Behav (2007) [Pubmed]
  21. Patterns and correlates of attempted suicide by heroin users over a 3-year period: findings from the Australian treatment outcome study. Darke, S., Ross, J., Williamson, A., Mills, K.L., Havard, A., Teesson, M. Drug. Alcohol. Depend (2007) [Pubmed]
  22. The Australian Treatment Outcome Study (ATOS): what have we learnt about treatment for heroin dependence?. Darke, S., Ross, J., Teesson, M. Drug. Alcohol. Rev (2007) [Pubmed]
  23. Reductions in heroin use are not associated with increases in other drug use: 2-year findings from the Australian Treatment Outcome Study. Darke, S., Williamson, A., Ross, J., Teesson, M. Drug. Alcohol. Depend (2006) [Pubmed]
  24. Cocaine-related fatalities in New South Wales, Australia 1993-2002. Darke, S., Kaye, S., Duflou, J. Drug. Alcohol. Depend (2005) [Pubmed]
  25. Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS). Darke, S., Ross, J., Teesson, M., Ali, R., Cooke, R., Ritter, A., Lynskey, M. J. Subst. Abuse. Treat (2005) [Pubmed]
  26. The impact of borderline personality disorder on 12-month outcomes for the treatment of heroin dependence. Darke, S., Ross, J., Williamson, A., Teesson, M. Addiction (2005) [Pubmed]
  27. Twelve-month outcomes for heroin dependence treatments: does route of administration matter?. Darke, S., Ross, J., Teesson, M. Drug. Alcohol. Rev (2005) [Pubmed]
  28. Non-fatal heroin overdose, treatment exposure and client characteristics: findings from the Australian treatment outcome study (ATOS). Darke, S., Williamson, A., Ross, J., Teesson, M. Drug. Alcohol. Rev (2005) [Pubmed]
  29. Drug driving among injecting drug users in Sydney, Australia: prevalence, risk factors and risk perceptions. Darke, S., Kelly, E., Ross, J. Addiction (2004) [Pubmed]
  30. Borderline personality disorder, antisocial personality disorder and risk-taking among heroin users: findings from the Australian Treatment Outcome Study (ATOS). Darke, S., Williamson, A., Ross, J., Teesson, M., Lynskey, M. Drug. Alcohol. Depend (2004) [Pubmed]
  31. Attempted suicide among injecting and noninjecting cocaine users in Sydney, Australia. Darke, S., Kaye, S. J. Urban. Health (2004) [Pubmed]
  32. Non-injecting routes of administration among entrants to three treatment modalities for heroin dependence. Darke, S., Hetherington, K., Ross, J., Lynskey, M., Teesson, M. Drug. Alcohol. Rev (2004) [Pubmed]
  33. The relationship of conduct disorder to attempted suicide and drug use history among methadone maintenance patients. Darke, S., Ross, J., Lynskey, M. Drug. Alcohol. Rev (2003) [Pubmed]
  34. Health service utilization and benzodiazepine use among heroin users: findings from the Australian Treatment Outcome Study (ATOS). Darke, S., Ross, J., Teesson, M., Lynskey, M. Addiction (2003) [Pubmed]
  35. Cocaine use in New South Wales, Australia, 1996-2000: 5 year monitoring of trends in price, purity, availability and use from the illicit drug reporting system. Darke, S., Kaye, S., Topp, L. Drug. Alcohol. Depend (2002) [Pubmed]
 
WikiGenes - Universities